Rigel Pharmaceuticals (RIGL) EBT (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly EBT of $11.7 million for Q1 2026, up 1.27% year-over-year from $11.5 million in Q1 2025, and down 48.68% quarter-over-quarter from $22.7 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) EBT (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' EBT history runs 17 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- In Q1 2026, EBT rose 1.27% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $122.0 million (up 219.94% YoY), while the FY2025 annual figure was $121.8 million, up 563.33% from the prior year.
- EBT for Q1 2026 stood at $11.7 million, down from $22.7 million in the prior quarter.
- The five-year high for EBT was $60.0 million in Q2 2025, with the low at -$27.4 million in Q1 2022.
- The 5-year median for EBT is -$61000.0 (2023), against an average of $3.9 million.
- The sharpest annual moves came in 2022 and 2024: EBT tumbled 166.5% in 2022, then jumped 25054.1% in 2024.
- Rigel Pharmaceuticals' EBT stood at $1.4 million in 2022, then slumped by 104.35% to -$61000.0 in 2023, then surged by 25054.1% to $15.2 million in 2024, then surged by 49.22% to $22.7 million in 2025, then plunged by 48.68% to $11.7 million in 2026.
- Business Quant data shows RIGL's EBT at $11.7 million in Q1 2026, $22.7 million in Q4 2025, and $27.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 23.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.59 Mn |
| Mar 31, 2026 | 11.66 Mn |
| Dec 31, 2025 | 22.71 Mn |
| Sep 30, 2025 | 27.62 Mn |
| Jun 30, 2025 | 59.98 Mn |
| Mar 31, 2025 | 11.51 Mn |
| Dec 31, 2024 | 15.22 Mn |
| Sep 30, 2024 | 12.42 Mn |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -8.25 Mn |
| Dec 31, 2023 | -61,000.00 |
| Sep 30, 2023 | -5.69 Mn |
| Jun 30, 2023 | -6.60 Mn |
| Mar 31, 2023 | -13.91 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | -19.04 Mn |
| Jun 30, 2022 | -13.49 Mn |
| Mar 31, 2022 | -27.45 Mn |
| Dec 31, 2021 | -22.70 Mn |
| Sep 30, 2021 | -21.09 Mn |